165 related articles for article (PubMed ID: 10516657)
1. Influence of nitrovasodilators and endothelin-1 on rheology of human blood in vitro.
Walter R; Mark M; Gaudenz R; Harris LG; Reinhart WH
Br J Pharmacol; 1999 Oct; 128(3):744-50. PubMed ID: 10516657
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
Marks GS; McLaughlin BE; Jimmo SL; Poklewska-Koziell M; Brien JF; Nakatsu K
Drug Metab Dispos; 1995 Nov; 23(11):1248-52. PubMed ID: 8591726
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.
Gryglewski RJ; Zembowicz A; Salvemini D; Taylor GW; Vane JR
Br J Pharmacol; 1992 Aug; 106(4):838-45. PubMed ID: 1327388
[TBL] [Abstract][Full Text] [Related]
4. Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.
MacAllister RJ; Calver AL; Riezebos J; Collier J; Vallance P
J Pharmacol Exp Ther; 1995 Apr; 273(1):154-60. PubMed ID: 7714761
[TBL] [Abstract][Full Text] [Related]
5. The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.
Hinz B; Schröder H
Pharm Res; 1999 May; 16(5):633-6. PubMed ID: 10350003
[TBL] [Abstract][Full Text] [Related]
6. Glyceryl trinitrate-induced vasodilation is inhibited by ultraviolet irradiation despite enhanced nitric oxide generation: evidence for formation of a nitric oxide conjugate.
Hussain AS; Crispino NH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Pharmacol Exp Ther; 1999 May; 289(2):895-900. PubMed ID: 10215668
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of nitrovasodilators and cyclic GMP on ET-1-activated Ca(2+)-permeable nonselective cation channel in rat aortic smooth muscle cells.
Minowa T; Miwa S; Kobayashi S; Enoki T; Zhang XF; Komuro T; Iwamuro Y; Masaki T
Br J Pharmacol; 1997 Apr; 120(8):1536-44. PubMed ID: 9113376
[TBL] [Abstract][Full Text] [Related]
8. Generation of nitric oxide from organic nitrovasodilators during passage through the coronary vascular bed and its role in coronary vasodilation and nitrate tolerance.
Schrör K; Woditsch I; Förster S
Blood Vessels; 1991; 28(1-3):62-6. PubMed ID: 1900446
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
10. Relative potency of nitrovasodilators on human placental vessels from normal and preeclamptic pregnancies.
González C; Cruz MA; Gallardo V; Miguel P; Carrasco G
Gynecol Obstet Invest; 1997; 43(4):219-24. PubMed ID: 9194618
[TBL] [Abstract][Full Text] [Related]
11. Effects of nitric oxide donors and inhibitors of nitric oxide signalling on endothelin- and serotonin-induced contractions in human placental arteries.
Sand AE; Andersson E; Fried G
Acta Physiol Scand; 2002 Mar; 174(3):217-23. PubMed ID: 11906320
[TBL] [Abstract][Full Text] [Related]
12. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa.
Lopez-Belmonte J; Whittle BJ; Moncada S
Br J Pharmacol; 1993 Jan; 108(1):73-8. PubMed ID: 8428217
[TBL] [Abstract][Full Text] [Related]
13. Effects of nitrovasodilators on the human fetal-placental circulation in vitro.
Zhang XQ; Kwek K; Read MA; Donoghue JF; Walters WA
Placenta; 2001 Apr; 22(4):337-46. PubMed ID: 11286570
[TBL] [Abstract][Full Text] [Related]
14. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo.
Ng SS; Pang CC
Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653
[TBL] [Abstract][Full Text] [Related]
15. Nitrovasodilator-induced relaxation and tolerance development in porcine vena cordis magna: dependence on intact endothelium.
Kojda G; Beck JK; Meyer W; Noack E
Br J Pharmacol; 1994 Jun; 112(2):533-40. PubMed ID: 7521258
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart.
Müller-Strahl G; Kottenberg K; Zimmer HG; Noack E; Kojda G
J Physiol; 2000 Jan; 522 Pt 2(Pt 2):311-20. PubMed ID: 10639106
[TBL] [Abstract][Full Text] [Related]
17. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
Schröder H; Ney P; Woditsch I; Schrör K
Eur J Pharmacol; 1990 Jul; 182(2):211-8. PubMed ID: 1697805
[TBL] [Abstract][Full Text] [Related]
18. Oxidative and adhesive responses of human neutrophils to nitrovasodilators in vitro: the role of protein kinases.
Klink M; Tchorzewski H; Sulowska Z
Mediators Inflamm; 2003 Dec; 12(6):345-53. PubMed ID: 14668094
[TBL] [Abstract][Full Text] [Related]
19. Vasorelaxant and platelet-suppressant potencies of four NO-donors.
Zembowicz A; Dudek RD; Radziszewski W; Swierkosz TA; Trybulec M; Gryglewski RJ
Pol J Pharmacol Pharm; 1990; 42(3):275-81. PubMed ID: 2124687
[TBL] [Abstract][Full Text] [Related]
20. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro.
Bath PM
Eur J Clin Pharmacol; 1993; 45(1):53-8. PubMed ID: 8405030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
